These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 3143016

  • 21. Recurrence of superficial bladder carcinoma after intravesical instillation of mitomycin-C. Comparison of exposure times.
    Giesbers AA, Van Helsdingen PJ, Kramer AE.
    Br J Urol; 1989 Feb; 63(2):176-9. PubMed ID: 2495144
    [Abstract] [Full Text] [Related]

  • 22. Mitomycin C intravesical therapy in noninvasive bladder cancer after failure on thiotepa.
    Issell BF, Prout GR, Soloway MS, Cummings KB, Brannen G, Veenema R, Flanagan M, Block NL, Summers JL, Levin EA.
    Cancer; 1984 Mar 01; 53(5):1025-8. PubMed ID: 6420039
    [Abstract] [Full Text] [Related]

  • 23. Intravesical chemotherapy: how effective is it?
    Heney NM.
    Urology; 1988 Mar 01; 31(3 Suppl):17-9. PubMed ID: 3126591
    [Abstract] [Full Text] [Related]

  • 24. Treatment of superficial bladder cancer with intravesical mitomycin C: analysis of immediate and long-term response in 70 patients.
    Soloway MS.
    J Urol; 1985 Dec 01; 134(6):1107-9. PubMed ID: 3932684
    [Abstract] [Full Text] [Related]

  • 25. Intravesical chemotherapy for superficial bladder cancer.
    Koontz WW.
    Urology; 1984 Apr 01; 23(4 Suppl):79-81. PubMed ID: 6424298
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Intravesical bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer.
    Shelley MD, Court JB, Kynaston H, Wilt TJ, Coles B, Mason M.
    Cochrane Database Syst Rev; 2003 Apr 01; (3):CD003231. PubMed ID: 12917955
    [Abstract] [Full Text] [Related]

  • 29. Introduction and overview of intravesical therapy for superficial bladder cancer.
    Soloway MS.
    Urology; 1988 Mar 01; 31(3 Suppl):5-16. PubMed ID: 3126593
    [Abstract] [Full Text] [Related]

  • 30. Single-dose perioperative mitomycin-C versus thiotepa for low-grade noninvasive bladder cancer.
    Faraj K, Chang YH, Rose KM, Habermann EB, Etzioni DA, Blodgett G, Castle EP, Humphreys MR, Tyson Ii MD.
    Can J Urol; 2019 Oct 01; 26(5):9922-9930. PubMed ID: 31629441
    [Abstract] [Full Text] [Related]

  • 31. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M, McGarry R, Kupelnick B.
    Anticancer Res; 2001 Oct 01; 21(1B):765-9. PubMed ID: 11299841
    [Abstract] [Full Text] [Related]

  • 32. Superficial bladder cancer: intravesical chemotherapy and tumour progression to muscle invasion or metastases.
    Smith G, Elton RA, Chisholm GD, Newsam JE, Hargreave TB.
    Br J Urol; 1986 Dec 01; 58(6):659-63. PubMed ID: 3099881
    [Abstract] [Full Text] [Related]

  • 33. Intravesical therapy for bladder cancer.
    Soloway MS.
    Urol Clin North Am; 1988 Nov 01; 15(4):661-9. PubMed ID: 3142129
    [Abstract] [Full Text] [Related]

  • 34. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP, Witjes JA, Oosterhof GO, Debruyne MJ.
    Semin Urol Oncol; 1996 Feb 01; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [Abstract] [Full Text] [Related]

  • 35. Approaches to the treatment of bladder cancer at Stanford.
    Torti FM.
    Cancer Chemother Pharmacol; 1987 Feb 01; 20 Suppl():S63-6. PubMed ID: 2444355
    [Abstract] [Full Text] [Related]

  • 36. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study.
    Martinez-Pineiro JA, Jimenez León J, Martinez-Pineiro L, Fiter L, Mosteiro JA, Navarro J, García Matres MJ, Cárcamo P.
    Prog Clin Biol Res; 1989 Feb 01; 310():237-52. PubMed ID: 2505269
    [Abstract] [Full Text] [Related]

  • 37. Effect of different local and systemic therapy upon urinary bladder cytology.
    Borgmann V, al-Abadi H, Friedrichs R, Nagel R.
    Urol Int; 1993 Feb 01; 50(1):21-6. PubMed ID: 8434422
    [Abstract] [Full Text] [Related]

  • 38. In vitro study of the interaction of doxorubicin, thiotepa, and mitomycin-C, agents used for intravesical chemotherapy of superficial bladder cancer.
    Seraphim LA, Perrapato SD, Slocum HK, Rustum YM, Huben RP.
    J Urol; 1991 Mar 01; 145(3):613-7. PubMed ID: 1900087
    [Abstract] [Full Text] [Related]

  • 39. Intensive intravesical chemotherapy in the treatment of flat carcinoma in situ: is it safe?
    Droller MJ, Walsh PC.
    J Urol; 1985 Dec 01; 134(6):1115-7. PubMed ID: 3932686
    [Abstract] [Full Text] [Related]

  • 40. Bladder wall calcification after topical mitomycin C.
    Alter AJ, Malek GH.
    J Urol; 1987 Nov 01; 138(5):1239-40. PubMed ID: 3118058
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.